Safety and Efficacy of Inclisiran in Hyperlipidemia: An Updated Meta‐Analysis of Randomised Controlled Trials

Safety and Efficacy of Inclisiran in Hyperlipidemia: An Updated Meta‐Analysis of Randomised Controlled Trials

<h3>Introduction</h3><p dir="ltr">Inclisiran, a small interfering RNA (siRNA), reduces the levels of low‐density lipoproteins (LDL) in the body by preventing the hepatic synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9). However, there is limited pooled d...

Full description

Saved in:
Bibliographic Details
Main Author: Jawad Basit (19231376) (author)
Other Authors: Mushood Ahmed (19231379) (author), Priyansha Singh (8265666) (author), Areeba Ahsan (22330525) (author), Eeshal Zulfiqar (22393264) (author), Javed Iqbal (2121922) (author), Maurish Fatima (19231394) (author), Prakash Upreti (12198871) (author), Mohammad Hamza (11505838) (author), M Chadi Alraies (9569721) (author)
Published: 2025
Subjects:
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Pharmacology and pharmaceutical sciences
hyperlipidemia
Inclisiran
meta-analysis
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items